Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Assets Average (2019 - 2025)

Inventiva (IVA) posted quarterly Assets Average of $246.5 million for Q4 2025, up 233.48% year-over-year from $73.9 million in Q4 2024, and up 49.53% quarter-over-quarter from $164.8 million in Q2 2025.

Analysis

Inventiva (IVA) Assets Average (2019 - 2025) Analysis & Trends

Inventiva's Assets Average history runs 7 years deep, the most recent figure standing at $246.5 million for Q4 2025.

  • In Q4 2025, Assets Average rose 233.48% year-over-year to $246.5 million; the TTM figure through Dec 2025 stood at $246.5 million (up 233.48% YoY), while the FY2025 annual figure was $208.8 million, up 106.75% from the prior year.
  • Assets Average for Q4 2025 stood at $246.5 million, up from $164.8 million in the prior quarter.
  • The five-year high for Assets Average was $246.5 million in Q4 2025, with the low at $47.8 million in Q2 2024.
  • The 5-year median for Assets Average is $97.7 million (2023), against an average of $115.0 million.
  • The sharpest annual moves came in 2022 and 2025: Assets Average plunged 53.55% in 2022, then jumped 245.03% in 2025.
  • Inventiva's Assets Average stood at $140.4 million in 2021, then slumped by 50.25% to $69.8 million in 2022, then dropped by 21.38% to $54.9 million in 2023, then soared by 34.64% to $73.9 million in 2024, then soared by 233.48% to $246.5 million in 2025.
  • Business Quant data shows IVA's Assets Average at $246.5 million in Q4 2025, $164.8 million in Q2 2025, and $73.9 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 3.29 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.82 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 2.09 Bn
10 Inventiva 893.85 Mn 893.85 Mn - 246.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 246.51 Mn
Jun 30, 2025 164.85 Mn
Dec 31, 2024 73.92 Mn
Jun 30, 2024 47.78 Mn
Dec 31, 2023 75.98 Mn
Jun 30, 2023 97.73 Mn
Jun 30, 2022 127.60 Mn
Dec 31, 2021 140.35 Mn
Jun 30, 2021 150.32 Mn
Mar 31, 2021 162.56 Mn
Dec 31, 2020 120.66 Mn
Dec 31, 2019 77.07 Mn